SEC charges two former Ariad executives with insider trading By: Boston Business Journal via Business Journals June 27, 2017 at 13:12 PM EDT The allegations stem from the Cambridge biotech's discussions with the FDA in 2012 and 2013 regarding cancer drug Iclusig. Read More >>
